Products and Services

Catalent will continue to offer DPI development and manufacturing services at the Nottingham, UK Juniper Pharma Services facility that was part of its recently completed acquisition of Juniper Pharmaceuticals, the company says. Catalent announced its intent to acquire Juniper in July 2018. The Nottingham facility was originally owned by Molecular Profiles, which … [Read more...] about Catalent completes acquisition of Juniper Pharma Services

According to DFE Pharma, the company has significantly increased production capacities of its excipients, including all of its inhalation grade lactose products. The company said that it achieved the improved supply through investments at facilities in the Netherlands, Germany, and India. Inhalation grade lactose is produced at the plant in Veghel, the … [Read more...] about DFE Pharma announces improved supply of inhalation grade lactose

Copley Scientific has announced the launch of an upgraded NGI Assistant for automated drug recovery from NGI cascade impactors for inhaler testing. According to Copley, the new model features a simplified interface and shorter cycle times compared to the previous model. The NGI Assistant automatically dispenses solvent into up to 3 NGI cup trays at a time, … [Read more...] about Copley Scientific introduces upgraded NGI Assistant for inhaler testing

Nanopharm Limited has announced an agreement with US-based Sciarra Laboratories that will pair Nanopharm's SmartTrack OINDP development services with Sciarra's GMP metered dose inhaler manufacturing services. Together, Nanopharm and Sciarra will comprise a CDMO with more than 30,000 square feet of research and manufacturing space, which the companies say "offers … [Read more...] about Nanopharm partners with Sciarra Laboratories to provide CDMO services for MDIs

In a business update, Gerresheimer announced that it has gained one large order for inhaler manufacturing in Europe but has lost another because "the customer's inhaler business fell short of its expectations." As a result, the company said, it plans to invest in a manufacturing facility in Horsovsky Tyn, the Czech Republic and will close a plant in Küssnacht, … [Read more...] about Gerresheimer gains one inhaler manufacturing order, loses another

Inhalation Sciences subsidiary Ziccum has been awarded a grant of 500,000 SEK (~ €48,600) by the EU's Horizon 2020 research and innovation project for scale up of its LaminarPace spray drying technology, the company said. A small scale version of LaminarPace is currently in use for creation of dry powder formulations of drugs, vaccines, and biologics. According to … [Read more...] about Ziccum gets Horizon 2020 grant for dry powder technology

Amiko Digital Health has announced that Portuguese health care group Luz Saúde has signed an agreement for the use of Amiko's Respiro inhaler monitoring platform for asthma and COPD management. Earlier this year, Amiko announced that the Respiro platform received the CE mark for use with Spiromax, Nexthaler, and Ellipta inhalers, and the company had received a … [Read more...] about Luz Saúde partners with Amiko Digital Health

Catalent has announced that it will acquire Juniper Pharma Services (formerly Molecular Profiles) along with its parent company Juniper Pharmaceuticals. Catalent will pay $11.50 per share to acquire all of Juniper Pharmaceuticals' stock. Juniper Pharmaceuticals acquired CDMO Molecular Profiles in 2015 and changed its name to Juniper Pharma Services. Juniper has … [Read more...] about Catalent acquires Juniper Pharmaceuticals

Swedish DPI developer Iconovo has announced a manufacturing, sales, and distribution agreement with Stevanato Group for its ICOcap dry powder inhaler. The capsule-based ICOcap device will be manufactured by Stevanato Group subsidiary Balda. According to the announcement, Stevanato Group has a sales and marketing presence in more than 150 countries. Iconovo CEO … [Read more...] about Stevanato Group to manufacture and sell Iconovo’s ICOcap inhaler